Close Menu

Mass General

The partners will develop a bench-top platform to isolate and explore the biology of rare cells at the protein, RNA, and DNA levels.

The partners will develop pharmacogenomic assays based on Mass General's genotyping platform.

The UK-based firm will provide Sanger with more than 200 genetically defined cell lines with cancer-causing mutations, which will guide researchers working on the Genomics of Drug Sensitivity in Cancer project.

The method, called low-quantity digital gene expression, or LQ-DGE, was published online last week in Nature Methods. Helicos said it is currently assessing the technique for its "potential to advance molecular diagnostic assays for patients suffering from breast and ovarian cancer."

Athena alleges that Ambry's sale of tests for certain types of diabetes infringes on patents that Athena licensed from its development partner Correlagen.

The 2007 survey, conducted by the MGH Institute for Health Policy, also suggests that academic life scientists with industry support withheld data or delayed publication due to commercial prospects more frequently than those with no industry support during that time.

Using an siRNA screen, a team of researchers from Boston and Maryland has identified a host of human proteins that appear to play a role in hepatitis C infection.

The instrument has been installed in the lab of Daniel Haber, who will explore the use of the system for use in characterizing circulating tumor cells.

Two studies appearing in the latest issue of the Journal of the American Medical Association examine the applicability of cardiovascular biomarkers for diagnostic and therapeutic development.


Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.